# US 2024/0417704 A1 · Modified helicases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0417704 A1
- Document ID: US20240417704A1
- Status: Published application
- Kind: A1
- Application number: 18/762,324
- Filed: 2024-07-02
- Published: 2024-12-19
- Earliest claimed: 2012-07-19
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies PLC
- Inventors: Andrew John Heron; James Anthony Clarke; Ruth Moysey; Elizabeth Jayne Wallace; Mark John Bruce; Lakmal Nishantha Jayasinghe; Domenico Caprotti; Szabolcs Soeroes; Luke McNeill; David Antoni Alves; Rebecca Victoria Bowen; John Milton
- Web page: https://patentgrep.com/patent/US20240417704A1

## CPC

- C12N 9/14: Hydrolases (3)
- C12N 9/90: Isomerases (5.)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Y 306/04012: DNA helicase (3.6.4.12)
- C12Y 599/01002: DNA topoisomerase (5.99.1.2)
- C12Y 599/01003: DNA topoisomerase (ATP-hydrolysing) (5.99.1.3)
- C07K 2319/80: containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The invention relates to modified helicases with reduced unbinding from polynucleotides. The helicases can be used to control the movement of polynucleotides and are particularly useful for sequencing polynucleotides.

## Claims

### Claim at position 1

-30. (canceled)

### Claim 31

A method of controlling the movement of a polynucleotide through a transmembrane pore, the method comprising:
(a) contacting the polynucleotide with the transmembrane pore and a helicase that comprises a polynucleotide binding domain, wherein two amino acid residues that are located on a surface of the helicase are covalently connected via a linkage between the two amino acid residues to form a covalently-closed structure, thereby controlling the movement of the polynucleotide through the transmembrane pore.

### Claim 32 (depends on 31)

The method of claim 31 further comprising:
(b) taking one or more measurements as the polynucleotide moves with respect to the transmembrane pore, wherein the one or more measurements are indicative of one or more characteristics of the polynucleotide.

### Claim 33 (depends on 32)

The method of claim 32, wherein the one or more characteristics are selected from (i) the length of the polynucleotide, (ii) the identity of the polynucleotide, (iii) the sequence of the polynucleotide, (iv) the secondary structure of the polynucleotide and (v) whether or not the polynucleotide is modified

### Claim 34 (depends on 33)

The method of claim 33, wherein the polynucleotide is modified by methylation, by oxidation, by damage, with one or more proteins or with one or more labels, tags or spacers.

### Claim 35 (depends on 32)

The method of claim 32, wherein the one or more characteristics of the polynucleotide are measured by electrical measurement and/or optical measurement.

### Claim 36 (depends on 35)

The method of claim 35, wherein the electrical measurement is a current measurement, an impedance measurement, a tunnelling measurement or a field effect transistor (FET) measurement.

### Claim 37

(canceled)

### Claim 38 (depends on 31)

The method of claim 31, wherein the method further comprises the step of applying a voltage across the transmembrane pore.

### Claim 39 (depends on 31)

The method of claim 31, wherein at least a portion of the polynucleotide is double stranded.

### Claim 40

(canceled)

### Claim 41 (depends on 31)

The method of claim 31, wherein the transmembrane pore is derived from a hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) and WZA.

### Claim at position 13

-59. (canceled)

### Claim 60 (depends on 31)

The method of claim 31, wherein at least one amino acid of the two amino acid residues is substituted with cysteine, a non-natural amino acid or 4-azido-L-phenylalanine (Faz).

### Claim 61 (depends on 31)

The method of claim 31, wherein the two amino acid residues that are located on the surface of the helicase are on one or more loop regions connecting α-helices and β-strands of the helicase and/or are spatially located proximal to the polynucleotide binding domain.

### Claim 62 (depends on 31)

The method of claim 31, wherein the helicase is (a) a Hel308 helicase, a RecD helicase, a TraI helicase, a TraI subgroup helicase, an XPD helicase; or (b) one of the helicases as set forth in SEQ ID NO: 10, 13, 16, 19, 22, 25, 28, 29, 32-34, 37-55, 58, 85, 126, 134, 138.

### Claim 63 (depends on 31)

The method of claim 31, wherein the helicase further comprises a second set of two amino acid residues in different structural domains of the helicase surrounding the polynucleotide binding domain that are covalently connected via a linkage between the two amino acid residues of the second set.

### Claim 64 (depends on 31)

The method of claim 31, wherein the linkage between the two amino acid residues comprises a peptide linker.

### Claim 65 (depends on 64)

The method of claim 64, wherein the peptide linker comprises a polynucleotide binding moiety.

### Claim 66 (depends on 31)

The method of claim 31, wherein the linkage between the two amino acid residues comprises a polyethyleneglycol (PEG), polysaccharide, polyamide, deoxyribonucleic acid (DNA) sequence, peptide nucleic acid (PNA), threose nucleic acid (TNA), or glycerol nucleic acid (GNA).

### Claim 67 (depends on 31)

The method of claim 31, wherein the helicase is a member of a helicase family selected from the group consisting of: Pif1-like helicases, Upf1-like helicases, UvrD/Rep helicases, Ski-like helicases, Rad3/XPD helicases, NS3/NPH-II helicases, DEAD helicases, DEAHi RHA helicases, RecG-like helicases, REcQ-like helicases, T1R-like helicases, Swi/Snf-like helicases, and Rig-I-like helicases.

### Claim 68 (depends on 31)

The method of claim 31, wherein the helicase is a member of a helicase subfamily selected from the group consisting of: RecD helicases, Upf1 helicases, PcrA helicases, Rep helicases, UvrD helicases, Hel308 helicases, Mtr4 helicases, XPD helicases, NS3 helicases, Mssl 16 helicases, Prp43 helicases, RecG helicases, RecQ helicases, T1R helicases, RapA helicases and Hef helicases.

### Claim 69 (depends on 31)

The method of claim 31, wherein the transmembrane pore is a β-barrel pore or an α-helix bundle pore.

### Claim 70 (depends on 31)

The method of claim 31, wherein at least one amino acid of the two amino acid residues is a cysteine that has been introduced into the helicase.
